Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-6

Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

Quick Stats
Studies 702
Trials 0
Score 2
2018 pubmed 15 citations

Lateral septum growth hormone secretagogue receptor affects food intake and motivation for sucrose reinforcement.

Terrill. Sarah J SJ; Wall. Kaylee D KD; Medina. Nelson D ND; Maske. Calyn B CB; Williams. Diana L DL

Key Findings

  • Activating GHSRs in the lateral septum (LS) increases chow intake in mice.
  • Blocking LS GHSRs with an antagonist reduces food consumption, especially at the start of the dark (active) phase.
  • Ghrelin in the dorsal LS boosts motivation to obtain sucrose, but LS GHSR blockade does not affect this motivation.

Practical Outcomes

  • For biohackers, the data suggest that ghrelin signaling in the LS contributes to how much you eat, so drugs that block GHSRs might help curb appetite, though delivering them to the LS is not feasible outside a lab. Systemic GHRP‑6 (an agonist) already raises appetite, and this study doesn’t change dosing recommendations. The findings are mainly of scientific interest rather than a new, actionable protocol.

Summary

The study shows that turning on ghrelin receptors (GHSRs) in a brain area called the lateral septum makes mice eat more, while blocking those receptors there makes them eat less. When ghrelin is activated specifically in the dorsal part of this region, mice work harder to get a sugary reward, but blocking the receptors doesn’t change that effort. The work was done by injecting substances directly into the brain, not by taking them orally or by injection into the bloodstream.

Abstract

The hormone ghrelin promotes eating and is widely considered to be a hunger signal. Ghrelin receptors, growth hormone secretagogue receptors (GHSRs), are found in a number of specific regions throughout the brain, including the lateral septum (LS), an area not traditionally associated with the control of feeding. Here we investigated whether GHSRs in the LS play a role in the control of food intake. We examined the feeding effects of ghrelin and the GHSR antagonists ([d-Lys<sup>3</sup>]-growth hormone-releasing peptide-6 and JMV-2959) at doses subthreshold for effect when delivered to the lateral ventricle. Intra-LS ghrelin significantly increased chow intake during the midlight phase, suggesting that pharmacological activation of LS GHSRs promotes feeding. Conversely, GHSR antagonist delivered to the LS shortly before dark onset significantly reduced chow intake. These data support the hypothesis that exogenous and endogenous stimulation of GHSRs in the LS influence feeding. Ghrelin is known to affect motivation for food, and the dorsal subdivision of LS (dLS) has been shown to play a role in motivation. Thus, we investigated the role of dLS GHSRs in motivation for food reward by examining operant responding for sucrose on a progressive ratio (PR) schedule. Intra-dLS ghrelin increased PR responding for sucrose, whereas blockade of LS GHSRs did not affect responding in either a fed or fasted state. Together these findings for the first time substantiate the LS as a site of action for ghrelin signaling in the control of food intake.

Study Information

Provider

pubmed

Year

2018

Date

2018-03-28T00:00:00.000Z

DOI

10.1152/ajpregu.00339.2017

Citations

15

References

40